NHS Ester-PEG4-Val-Ala-PBD

Catalog No. :
ACDEJS331
CAS No. :
-
Molecular Formula :
C66H76N8O18
Molecular Weight :
1269.37

IUPAC Name:2,5-dioxopyrrolidin-1-yl (2R,5R)-5-isopropyl-1-((4-((S)-7-methoxy-8-(3-(((S)-7-methoxy-2-(4-methoxyphenyl)-5-oxo-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)propoxy)-5-oxo-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-2-yl)phenyl)amino)-2-methyl-1,4,7-trioxo-10,13,16,19-tetraoxa-3,6-diazadocosan-22-oate

NHS Ester-PEG4-Val-Ala-PBD structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameNHS Ester-PEG4-Val-Ala-PBD
IUPAC Name2,5-dioxopyrrolidin-1-yl (2R,5R)-5-isopropyl-1-((4-((S)-7-methoxy-8-(3-(((S)-7-methoxy-2-(4-methoxyphenyl)-5-oxo-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)propoxy)-5-oxo-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-2-yl)phenyl)amino)-2-methyl-1,4,7-trioxo-10,13,16,19-tetraoxa-3,6-diazadocosan-22-oate
Molecular FormulaC66H76N8O18
Molecular Weight1269.37
SMILESO=C([C@@H](C)NC([C@@H](C(C)C)NC(CCOCCOCCOCCOCCC(ON1C(CCC1=O)=O)=O)=O)=O)NC2=CC=C(C=C2)C3=CN4C(C5=CC(OC)=C(C=C5N=C[C@]4([H])C3)OCCCOC6=C(C=C7C(N8[C@@](C=NC7=C6)([H])CC(C(C=C9)=CC=C9OC)=C8)=O)OC)=O
InChI KeyULBDKSIWAYKCQR-LIVRBHPVSA-N

Synthetic Route by SureRoute

1. ACDEJS331 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDEJS331 route product structure diagram
    ACDEJS331-
Inquiry

2. ACDEJS331 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDEJS331 route product structure diagram
    ACDEJS331-
Inquiry

Comments (0)